...
首页> 外文期刊>Urologic oncology >Adjuvant vs. salvage radiotherapy for patients at high risk for recurrence after radical prostatectomy
【24h】

Adjuvant vs. salvage radiotherapy for patients at high risk for recurrence after radical prostatectomy

机译:佐剂对患者的副催化,患者在激进前列腺切除术后复发的高风险

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Prostate cancer patients with adverse pathologic factors (i.e., positive surgical margin. pT3 disease) after radical prostatectomy are more likely not cured ( >60%) than cured by surgery alone. Adjuvant radiotherapy compared with observation reduces recurrence by 49% to 57%, may improve overall survival, and improves long-term quality of life without increased long-term patient-reported urinary or gastrointestinal tract symptoms. Despite these results. adjuvant radiotherapy is uncommonly received by patients with these adverse factors.
机译:前列腺癌患者具有不利病理因素(即,正面外科缘。PT3疾病)在自由基前列腺切除术后不受治愈(> 60%),而不是单独的手术治愈。 佐剂放疗与观察相比减少了49%〜57%的复发,可以改善整体存活,并提高长期生活质量,而无需增加长期患者报告的尿或胃肠道症状。 尽管这些结果。 辅助放射治疗因这些不利因素的患者罕见。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号